Cancers | Feature Papers from the First Half of 2024 in the Section “Tumor Microenvironment”

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2024 in the Section “Tumor Microenvironment”, which are listed below:

1. “Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression”
by Raffaele Strippoli, Reyhaneh Niayesh-Mehr, Maryam Adelipour, Arezoo Khosravi, Ali Zarrabi and Abdolamir Allameh
Cancers 2024, 16(4), 807; https://doi.org/10.3390/cancers16040807
Available online: http://www.mdpi.com/2072-6694/16/4/807

2. “CSF-1R in Cancer: More than a Myeloid Cell Receptor”
by Francesca Cersosimo, Silvia Lonardi, Cristina Ulivieri, Paolo Martini, William Vermi, Antonio Giordano and Emanuele Giurisato
Cancers 2024, 16(2), 282; https://doi.org/10.3390/cancers16020282
Available online: http://www.mdpi.com/2072-6694/16/2/282

3. “Chimeric Antigen Receptor T Cell and Chimeric Antigen Receptor NK Cell Therapy in Pediatric and Adult High-Grade Glioma—Recent Advances”
by Adrian Kowalczyk, Julia Zarychta, Anna Marszołek, Joanna Zawitkowska and Monika Lejman
Cancers 2024, 16(3), 623; https://doi.org/10.3390/cancers16030623
Available online: http://www.mdpi.com/2072-6694/16/3/623

4. “Symptomatic Benign Prostatic Hyperplasia with Suppressed Epigenetic Regulator HOXB13 Shows a Lower Incidence of Prostate Cancer Development”
by Nimrod S. Barashi, Tiandao Li, Duminduni H. Angappulige, Bo Zhang, Harry O’Gorman, Charles U. Nottingham, Anup S. Shetty, Joseph E. Ippolito, Nupam P.Mahajan, Eric H. Kim et al.
Cancers 2024, 16(1), 213; https://doi.org/10.3390/cancers16010213
Available online: http://www.mdpi.com/2072-6694/16/1/213

5. “CD45-Directed CAR-T Cells with CD45 Knockout Efficiently Kill Myeloid Leukemia and Lymphoma Cells In Vitro Even after Extended Culture”
by Maraike Harfmann, Tanja Schröder, Dawid Głów, Maximilian Jung, Almut Uhde, Nicolaus Kröger, Stefan Horn, Kristoffer Riecken, Boris Fehse and Francis A. Ayuk
Cancers 2024, 16(2), 334; https://doi.org/10.3390/cancers16020334
Available online: http://www.mdpi.com/2072-6694/16/2/334

6. “The Aryl Hydrocarbon Receptor: Impact on the Tumor Immune Microenvironment and Modulation as a Potential Therapy”
by Brian D. Griffith and Timothy L. Franke
Cancers 2024, 16(3), 472; https://doi.org/10.3390/cancers16030472
Available online: http://www.mdpi.com/2072-6694/16/3/472

7. “Therapeutic Immunomodulation in Gastric Cancer”
by Venu Akkanapally, Xue-Feng Bai and Sujit Basu
Cancers 2024, 16(3), 560; https://doi.org/10.3390/cancers16030560
Available online: http://www.mdpi.com/2072-6694/16/3/560

8. “Therapeutic Potential for Sphingolipids in Inflammatory Bowel Disease and Colorectal Cancer”
by Keila S. Espinoza and Ashley J. Snider
Cancers 2024, 16(4), 789; https://doi.org/10.3390/cancers16040789
Available online: http://www.mdpi.com/2072-6694/16/4/789

9. “The Role of Curcumin in Cancer: A Focus on the PI3K/Akt Pathway”
by Vasiliki Zoi, Athanassios P. Kyritsis, Vasiliki Galani, Diamanto Lazari, Spyridon Voulgaris and Georgios A. Alexiou
Cancers 2024, 16(8), 1554; https://doi.org/10.3390/cancers16081554
Available online: http://www.mdpi.com/2072-6694/16/8/1554

10. “Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence”
by Mariia Ivanova, Carlo Pescia, Eltjona Mane, Dario Trapani, Konstantinos Venetis, Chiara Frascarelli, Giulia Cursano, Elham Sajjadi, Francesca Maria Porta, Cristian Scatena et al.
Cancers 2024, 16(11), 1981; https://doi.org/10.3390/cancers16111981
Available online: http://www.mdpi.com/2072-6694/16/11/1981

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office